Sign up / Login
  • Sign-in
  • Sign up

Archived - Understanding COVID-19 Vaccine Efficacy

Manage

Add to lists

Only you can see these lists - view your lists on the My Learning page.


Unsave

This will also remove this resource from any lists you have added it to.

Yes, I would like to unsave
Type:
  Video
Duration:
3 minutes
Presented by:
UCLA Child & Youth Behavioral Health Center of Excellence
Featuring:
Hilary Aralis, PhD and Domenique Harrison, MA, MPH
Series:
Moving the Needle Towards Acceptance: Discussing the COVID-19 Vaccine With Our Los Angeles Community
Relevant categories:
Community Engagement
This is a video.
Use the controls provided by the embedded content to watch the video.
This content has been archived.

Overview


When a vaccine is said to have high efficacy, it means it is successful in warding off infectious diseases and illnesses. For the COVID-19 vaccine, high efficacy, practicing health-conscious behaviors, and limiting exposure to infection, can help reduce one's chance of infection. Here to discuss COVID-19 vaccine efficacy and other factors which can impact one's risk of COVID-19 infection is Dr. Hilary Aralis, Assistant Professor and Biostatician at the UCLA Fielding School of Public Health.

  Keywords: COVID-19, health
  Public link for sharing: https://learn.wellbeing4la.org/detail?id=17177&k=archived  
Copied!

Learning objectives


  • Explain that clinical trials were not designed to estimate someone’s chance of getting COVID-19
  • Describe that one’s chances of getting COVID-19 depends on factors like the prevalence in one’s community, exposures encountered, and time range
  • Define vaccine efficacy; analyze what a vaccine efficacy of 95% suggests, that for two individuals who are otherwise comparable, it is expected the person who received the vaccine is twenty times less likely to develop symptomatic COVID-19

Related items


Clinical Trials: Efficacy, Safety, and Inclusivity

A greater understanding of population demographics, history, processes used in clinical trials can be crucial to promote vaccine acceptance. Here to discuss clinical trials the research necessary to evaluate safety, efficacy, and effectiveness is Dr. Hilary Aralis, Assistant Professor and Biostatician at the UCLA Fielding School of Public Health.

 Video
  7 minutes
What Is Vaccine Hesitancy and Herd Immunity?

COVID-19 vaccine acceptance is critical to creating indirect protection for our greater community. Delaying receipt of the COVID-19 vaccine may result in higher infection rates and potential outbreaks across multiple communities. Here to discuss vaccine hesitancy, herd immunity, and effective strategies to promote vaccine acceptance is Dr. Jae Lee, Professor and Epidemiologist at the UCLA David Geffen School of Medicine and UCLA Fielding School of Public Health.

 Video
  5 minutes
Added on 9/13/2021   ·   Last updated on 9/13/2021
Public Partnership for Wellbeing  
Copyright © 2019-2026
University of California at Los Angeles
About   |   Terms   |   Privacy   |   Contact
Way to go!
View your badges
Saved! (Manage)
Unsaved
Changes saved! (Manage)
Are you sure you want to unsave this resource?